These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 19487649

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Cortical remyelination: a new target for repair therapies in multiple sclerosis.
    Chang A, Staugaitis SM, Dutta R, Batt CE, Easley KE, Chomyk AM, Yong VW, Fox RJ, Kidd GJ, Trapp BD.
    Ann Neurol; 2012 Dec; 72(6):918-26. PubMed ID: 23076662
    [Abstract] [Full Text] [Related]

  • 24. [Regenerative capacity in multiple sclerosis].
    Lubetzki C.
    Bull Acad Natl Med; 2008 Mar; 192(3):495-504; discussion 505-6. PubMed ID: 18819695
    [Abstract] [Full Text] [Related]

  • 25. Growth-associated protein 43 in lesions and cerebrospinal fluid in multiple sclerosis.
    Teunissen CE, Dijkstra CD, Jasperse B, Barkhof F, Vanderstichele H, Vanmechelen E, Polman CH, Bö L.
    Neuropathol Appl Neurobiol; 2006 Jun; 32(3):318-31. PubMed ID: 16640650
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Vanishing MS T2-bright lesions before puberty: a distinct MRI phenotype?
    Chabas D, Castillo-Trivino T, Mowry EM, Strober JB, Glenn OA, Waubant E.
    Neurology; 2008 Sep 30; 71(14):1090-3. PubMed ID: 18824673
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Multiple sclerosis - remyelination failure as a cause of disease progression.
    Hagemeier K, Brück W, Kuhlmann T.
    Histol Histopathol; 2012 Mar 30; 27(3):277-87. PubMed ID: 22237705
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis?
    Williams A, Piaton G, Aigrot MS, Belhadi A, Théaudin M, Petermann F, Thomas JL, Zalc B, Lubetzki C.
    Brain; 2007 Oct 30; 130(Pt 10):2554-65. PubMed ID: 17855378
    [Abstract] [Full Text] [Related]

  • 35. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
    Benedetti B, Rovaris M, Rocca MA, Caputo D, Zaffaroni M, Capra R, Bertolotto A, Martinelli V, Comi G, Filippi M.
    Mult Scler; 2009 Jul 30; 15(7):789-94. PubMed ID: 19465450
    [Abstract] [Full Text] [Related]

  • 36. Longitudinal changes in myelin water fraction in two MS patients with active disease.
    Vavasour IM, Laule C, Li DK, Oger J, Moore GR, Traboulsee A, MacKay AL.
    J Neurol Sci; 2009 Jan 15; 276(1-2):49-53. PubMed ID: 18822435
    [Abstract] [Full Text] [Related]

  • 37. MALDI imaging mass spectrometry analysis-A new approach for protein mapping in multiple sclerosis brain lesions.
    Maccarrone G, Nischwitz S, Deininger SO, Hornung J, König FB, Stadelmann C, Turck CW, Weber F.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar 15; 1047():131-140. PubMed ID: 27461358
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.